189 related articles for article (PubMed ID: 14638881)
1. A population based epidemiological study on myasthenia gravis in Estonia.
Oöpik M; Kaasik AE; Jakobsen J
J Neurol Neurosurg Psychiatry; 2003 Dec; 74(12):1638-43. PubMed ID: 14638881
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of seropositive myasthenia gravis in Greece.
Poulas K; Tsibri E; Kokla A; Papanastasiou D; Tsouloufis T; Marinou M; Tsantili P; Papapetropoulos T; Tzartos SJ
J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):352-6. PubMed ID: 11511710
[TBL] [Abstract][Full Text] [Related]
3. A national epidemiological study of Myasthenia Gravis in Australia.
Gattellari M; Goumas C; Worthington JM
Eur J Neurol; 2012 Nov; 19(11):1413-20. PubMed ID: 22469211
[TBL] [Abstract][Full Text] [Related]
4. Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989.
Christensen PB; Jensen TS; Tsiropoulos I; Sørensen T; Kjaer M; Højer-Pedersen E; Rasmussen MJ; Lehfeldt E; de Fine Olivarius B
Neurology; 1993 Sep; 43(9):1779-83. PubMed ID: 8414031
[TBL] [Abstract][Full Text] [Related]
5. Myasthenia gravis on the Dutch antilles: an epidemiological study.
Holtsema H; Mourik J; Rico RE; Falconi JR; Kuks JB; Oosterhuis HJ
Clin Neurol Neurosurg; 2000 Dec; 102(4):195-198. PubMed ID: 11154803
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of myasthenia gravis in Ontario, Canada.
Breiner A; Widdifield J; Katzberg HD; Barnett C; Bril V; Tu K
Neuromuscul Disord; 2016 Jan; 26(1):41-6. PubMed ID: 26573434
[TBL] [Abstract][Full Text] [Related]
7. Incidence and prevalence of myasthenia gravis in the county of the coast and Gorski kotar, Croatia, 1976 through 1996.
Zivadinov R; Jurjevic A; Willheim K; Cazzato G; Zorzon M
Neuroepidemiology; 1998; 17(5):265-72. PubMed ID: 9705586
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of myasthenia gravis in Northern Portugal: Frequency estimates and clinical epidemiological distribution of cases.
Santos E; Coutinho E; Moreira I; Silva AM; Lopes D; Costa H; Silveira F; Nadais G; Morais H; Martins J; Branco MC; Veiga A; Silva RS; Ferreira A; Sousa F; Freijo M; Matos I; André R; Negrão L; Fraga C; Santos M; Sampaio M; Lopes C; Leite MI; Gonçalves G
Muscle Nerve; 2016 Sep; 54(3):413-21. PubMed ID: 26851892
[TBL] [Abstract][Full Text] [Related]
9. The Epidemiology of Myasthenia Gravis in Korea.
Lee HS; Lee HS; Shin HY; Choi YC; Kim SM
Yonsei Med J; 2016 Mar; 57(2):419-25. PubMed ID: 26847295
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of myasthenia gravis in the Catalan county of Osona.
Aragonès JM; Altimiras J; Roura P; Alonso F; Bufill E; Munmany A; Alfonso S; Illa I
Neurologia; 2017; 32(1):1-5. PubMed ID: 25449965
[TBL] [Abstract][Full Text] [Related]
11. A nationwide epidemiological study of myasthenia gravis in Latvia.
Zieda A; Ravina K; Glazere I; Pelcere L; Naudina MS; Liepina L; Kamsa I; Kurjane N; Woodhall M; Jacobson L; Leite MI; Tandon K; Kenina V
Eur J Neurol; 2018 Mar; 25(3):519-526. PubMed ID: 29194859
[TBL] [Abstract][Full Text] [Related]
12. Clinical and laboratory-reconfirmed myasthenia gravis: a population-based study.
Oöpik M; Puksa L; Lüüs SM; Kaasik AE; Jakobsen J
Eur J Neurol; 2008 Mar; 15(3):246-52. PubMed ID: 18190510
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983-1992).
Lavrnić D; Jarebinski M; Rakocević-Stojanović V; Stević Z; Lavrnić S; Pavlović S; Trikić R; Tripković I; Nesković V; Apostolski S
Acta Neurol Scand; 1999 Sep; 100(3):168-74. PubMed ID: 10478580
[TBL] [Abstract][Full Text] [Related]
14. Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa.
Mombaur B; Lesosky MR; Liebenberg L; Vreede H; Heckmann JM
Muscle Nerve; 2015 Apr; 51(4):533-7. PubMed ID: 25060190
[TBL] [Abstract][Full Text] [Related]
15. Geographical distribution of a seropositive myasthenia gravis population.
Heldal AT; Eide GE; Gilhus NE; Romi F
Muscle Nerve; 2012 Jun; 45(6):815-9. PubMed ID: 22581533
[TBL] [Abstract][Full Text] [Related]
16. Diversity in mental fatigue and social profile of patients with myasthenia gravis in two different Northern European countries.
Sabre L; Westerberg E; Liik M; Punga AR
Brain Behav; 2017 Apr; 7(4):e00653. PubMed ID: 28413704
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of myasthenia gravis in northwestern Sardinia.
Aiello I; Pastorino M; Sotgiu S; Pirastru MI; Sau GF; Sanna G; Rosati G
Neuroepidemiology; 1997; 16(4):199-206. PubMed ID: 9267837
[TBL] [Abstract][Full Text] [Related]
18. Incidence and characteristics of Myasthenia gravis in Dar Es Salaam, Tanzania.
Matuja WB; Aris EA; Gabone J; Mgaya EM
East Afr Med J; 2001 Sep; 78(9):473-6. PubMed ID: 11921580
[TBL] [Abstract][Full Text] [Related]
19. Incidence of myasthenia gravis in the province of Ferrara: a community-based study.
Casetta I; Fallica E; Govoni V; Azzini C; Tola M; Granieri E
Neuroepidemiology; 2004; 23(6):281-4. PubMed ID: 15297794
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands.
Niks EH; Kuks JB; Verschuuren JJ
J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):417-8. PubMed ID: 17056627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
